scholarly journals Idiopathic Neonatal Subpial Hemorrhage with Underlying Cerebral Infarct: Imaging Features and Clinical Outcome

2020 ◽  
Vol 42 (1) ◽  
pp. 185-193
Author(s):  
Z. Assis ◽  
A. Kirton ◽  
A. Pauranik ◽  
M. Sherriff ◽  
X.-C. Wei
Author(s):  
Ga Young Yoon ◽  
Joo Hee Cha ◽  
Hak Hee Kim ◽  
Hee Jung Shin ◽  
Eun Young Chae ◽  
...  

Background: Metaplastic breast cancer (MC) is a rare disease, thus it is difficult to study its clinical outcomes. Objective: To investigate whether any clinicopathological or imaging features were associated with clinical outcome in MC. Methods: We retrospectively evaluated the clinicopathological and imaging findings, and the clinical outcomes of seventy-two pathologically confirmed MCs. We then compared these parameters between triple-negative (TNMC) and non-TNMCs (NTNMC). Results: Oval or round shape, and not-circumscribed margin were the most common findings on mammography, ultrasound (US), and magnetic resonance imaging (MRI). It was mostly a mass without calcification on mammography, and revealed complex or hypoechoic echotexture, and posterior acoustic enhancement on US, and rim enhancement, wash-out kinetics, peritumoral edema, and intratumoral necrosis on MRI. Of all 72, 64 were TNMCs, and eight were NTNMCs. Clinicopathological and imaging findings were similar between the two groups, except that MRI showed peritumoral edema more frequently in TNMCs than NTNMCs (p=0.045). There were 21 recurrences and 13 deaths. Multivariable analysis showed that larger tumor size and co-existing DCIS were significantly predictive of Disease free survival (DFS), and larger tumor size and neoadjuvant chemotherapy were significantly predictive of overall survival (OS). Conclusion: MC showed characteristic imaging findings, and some variables associated with survival outcome may help to predict prognosis.


2019 ◽  
Vol 4 (12) ◽  
pp. 668-677 ◽  
Author(s):  
Olga D. Savvidou ◽  
Panagiotis Koutsouradis ◽  
Ioanna K. Bolia ◽  
Angelos Kaspiris ◽  
George D. Chloros ◽  
...  

Soft tissue tumours of the elbow are mostly benign. Malignant tumours in this area, although uncommon, often present unique clinical and histopathological characteristics that are helpful for diagnosis. Management of soft tissue tumours around the elbow may be challenging because of their rarity and the proximity to neurovascular structures. Careful staging, histological diagnosis and treatment are essential to optimize clinical outcome. A missed or delayed diagnosis or an improperly executed biopsy may have devastating consequences for the patient. This article reviews the most common benign and malignant soft tissue tumours of the elbow and discusses the clinicopathological findings, imaging features and current therapeutic concepts. Cite this article: EFORT Open Rev 2019;4:668-677. DOI: 10.1302/2058-5241.4.190002


Author(s):  
Christoph Rehnitz ◽  
Simon David Sprengel ◽  
Burkhard Lehner ◽  
Karl Ludwig ◽  
Georg Omlor ◽  
...  

2016 ◽  
Vol 58 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Trevor W. Moore ◽  
R. Timothy Bentley ◽  
Sarah A. Moore ◽  
Michele Provencher ◽  
Emma E. Warry ◽  
...  

1993 ◽  
Vol 47 (1) ◽  
pp. 94
Author(s):  
R.T. Cunningham ◽  
M. Watt ◽  
J Winder ◽  
S McKinstry ◽  
C.F. Johnston ◽  
...  

1993 ◽  
Vol 3 (2) ◽  
pp. 86-93 ◽  
Author(s):  
J.M. Wardlaw ◽  
M.S. Dennis ◽  
R.I. Lindley ◽  
C.P. Warlow ◽  
P.A.G. Sandercock ◽  
...  

2014 ◽  
Vol 87 (1038) ◽  
pp. 20140123 ◽  
Author(s):  
B S Somarouthu ◽  
A B Shinagare ◽  
M H Rosenthal ◽  
H Tirumani ◽  
J L Hornick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document